Facebook with Latestnigeriannews  Twieet with latestnigeriannews  RSS Page Feed
Home  |  All Headlines  |  Punch  |  Thisday  |  Daily Sun  |  Vanguard   |  Guardian  |  The Nation  |  Daily Times  |  Daily Trust  |  Daily Independent
World  |  Sports  |  Technology  |  Entertainment  |  Business  |  Politics  |  Tribune  |  Leadership  |  National Mirror  |  BusinessDay  |  More Channels...

Viewing Mode:

Archive:

  1.     Tool Tips    
  2.    Collapsible   
  3.    Collapsed     
Click to view all Entertainment headlines today

Click to view all Sports headlines today

A cheaper version of a blockbuster drug just launched at a 35% discount ' and it could save the US billions

Published by Business Insider on Mon, 24 Jul 2017


SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said it started US sales of its copy of Johnson & Johnson's rheumatoid arthritis drug Remicade on Monday - a move set to further undermine sales of the U.S. firm's top-selling drug.It is the second cheaper biosimilar version of Remicade to be sold after Pfizer Inc's Inflectra Remicade had U.S. sales of $4.8 billion last year, but January-June sales fell 8.2 percent from a year earlier to $2.2 billion on its new competition. Samsung's biosimilar, calledRenflexis, will come in at a 35% discount to Remicade's list price.A Johnson & Johnson unit, Janssen Biotech Inc, has sought a preliminary or permanent U.S. court injunction to block Bioepis's version, arguing that the South Korean firm violated three of its patents. A hearing for the lawsuit has yet to be scheduled."We are confident we do not infringe on Janssen's patents," Samsung Bioepis spokesman Mingi Hyun told Reuters in a statement.Samsung Bioepis, an unlisted unit of contract drug manufacturer Samsung BioLogics Co Ltd, received U.S regulatory approval to launch its biosimilar, Renflexis, in April. Biosimilars are lower-cost versions of complex biotech drugs, and Bioepis has focused on developing copies of some of the world's top selling drugs.Drugmakers in the past have pushed ahead with sales of products that were subject to patent litigation, but they can face heavy penalties if they lose in court.A U.S. judge in 2013 awarded AstraZeneca Plc $76 million in damages from generic drug maker Apotex for patent infringement for AstraZeneca's heartburn drug Prilosec, or the equivalent of 50 percent of profits generated during the three-and-a-half-year period Apotex sold a generic version of Prilosec.SEE ALSO:A former biotech executive who's living with terminal cancer wants to reset expectations about new cancer treatmentsDON'T MISS:The 10 most popular prescription drugs in the USJoin the conversation about this storyNOW WATCH: See how geologists scoop molten-hot lava into a bucket for testing
Click here to read full news..

All Channels Nigerian Dailies: Punch  |  Vanguard   |  The Nation  |  Thisday  |  Daily Sun  |  Guardian  |  Daily Times  |  Daily Trust  |  Daily Independent  |   The Herald  |  Tribune  |  Leadership  |  National Mirror  |  BusinessDay  |  New Telegraph  |  Peoples Daily  |  Blueprint  |  Nigerian Pilot  |  Sahara Reporters  |  Premium Times  |  The Cable  |  PM News  |  APO Africa Newsroom

Categories Today: World  |  Sports  |  Technology  |  Entertainment  |  Business  |  Politics  |  Columns  |  All Headlines Today

Entertainment (Local): Linda Ikeji  |  Bella Naija  |  Tori  |  Pulse  |  The NET  |  DailyPost  |  Information Nigeria  |  Gistlover  |  Lailas Blog  |  Miss Petite  |  Olufamous  |  Stella Dimoko Korkus Blog  |  Ynaija  |  All Entertainment News Today

Entertainment (World): TMZ  |  Daily Mail  |  Huffington Post

Sports: Goal  |  African Football  |  Bleacher Report  |  FTBpro  |  Kickoff  |  All Sports Headlines Today

Business & Finance: Nairametrics  |  Nigerian Tenders  |  Business Insider  |  Forbes  |  Entrepreneur  |  The Economist  |  BusinessTech  |  Financial Watch  |  BusinessDay  |  All Business News Headlines Today

Technology (Local): Techpoint  |  TechMoran  |  TechCity  |  Innovation Village  |  IT News Africa  |  Technology Times  |  Technext  |  Techcabal  |  All Technology News Headlines Today

Technology (World): Techcrunch  |  Techmeme  |  Slashdot  |  Wired  |  Hackers News  |  Engadget  |  Pocket Lint  |  The Verge

International Networks:   |  CNN  |  BBC  |  Al Jazeera  |  Yahoo

Forum:   |  Nairaland  |  Naij

Other Links: Home   |  Nigerian Jobs